Clinical Trial Update: Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED) [Phase 4]

View source ↗

Summary

Phase 4 safety study of CAELYX (pegylated liposomal doxorubicin) in metastatic breast cancer patients previously treated with anthracyclines was terminated; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Caelyx (liposomal doxorubicin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Breast Neoplasm | Phase 4 | Status: TERMINATED | Results posted: 2010-03-10